Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 8, 2006, Pages 2666-2672

  Rotem, Shahar ^a   Radzishevsky, Inna ^a   Mor, Amram ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIUM LIPOPOLYSACCHARIDE; DERMASEPTIN; IB 367; LYSINE; PEXIGANAN ACETATE; POLYPEPTIDE ANTIBIOTIC AGENT;

AMINO TERMINAL SEQUENCE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONJUGATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOPLASM; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; ERYTHROCYTE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIPOPHILICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHOSPHOLIPID MEMBRANE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN BINDING; STRUCTURE ACTIVITY RELATION; SURFACE PLASMON RESONANCE;

ACYLATION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMPHIBIAN PROTEINS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CHEMISTRY, PHYSICAL; CIRCULAR DICHROISM; ERYTHROCYTES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; HYDROPHOBICITY; INHIBITORY CONCENTRATION 50; KINETICS; MICROBIAL SENSITIVITY TESTS; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PLASMON RESONANCE;

EID: 33746867147     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00030-06     Document Type: Article

References (53)

1. Allende, D., and T. J. McIntosh. 2003. Lipopolysaccharides in bacterial membranes act like cholesterol in eukaryotic plasma membranes in providing protection against melittin-induced bilayer lysis. Biochemistry 42:1101-1108.
2. Andres, E., and J. L. Dimarcq. 2005. Clinical development of antimicrobial peptides. Int. J. Antimicrob. Agents 25:448-449.
3. Balaban, N., Y. Gov, A. Giacometti, O. Cirioni, R. Ghiselli, F. Mocchegiani, F. Orlando, G. D'Amato, V. Saba, G. Scalise, S. Bernes, and A. Mor. 2004. A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. Antimicrob. Agents Chemother. 48:2544-2550.
4. Blondelle, S. E., and R. A. Houghten. 1991. Hemolytic and antimicrobial activities of the twenty-four individual omission analogues of melittin. Biochemistry 30:4671-4678.
5. Blondelle, S. E., and K. Lohner. 2000. Combinatorial libraries: a tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure-activity relationship studies. Biopolymers 55:74-87.
6. Blondelle, S. E., E. Takahashi, R. A. Houghten, and E. Perez-Paya. 1996. Rapid identification of compounds with enhanced antimicrobial activity by using conformationally defined combinatorial libraries. Biochem. J. 313:141-147.
7. Brand, G. D., J. R. Leite, L. P. Silva, S. Albuquerque, M. V. Prates, R. B. Azevedo, V. Carregaro, J. S. Silva, V. C. Sa, R. A. Brandao, and C. Bloch, Jr. 2002. Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta. Anti-Trypanosoma cruzi activity without cytotoxicity to mammalian cells. J. Biol. Chem. 277:49332-49340.
8. Chalk, R., H. Townson, and P. J. Ham. 1995. Brugia pahangi: the effects of cecropins on microfilariae in vitro and in Aedes aegypti. Exp. Parasitol. 80:401-406.
9. Chen, T., L. Tang, and C. Shaw. 2003. Identification of three novel Phyllomedusa sauvagei dermaseptins (sVI-sVIII) by cloning from a skin secretion-derived cDNA library. Regul. Pept. 116:139-146.
10. Chicharro, C., C. Granata, R. Lozano, D. Andreu, and L. Rivas. 2001. N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide. Antimicrob. Agents Chemother. 45:2441-2449.
11. Dagan, A., L. Efron, L. Gaidukov, A. Mor, and H. Ginsburg. 2002. In vitro antiplasmodium effects of dermaseptin S4 derivatives. Antimicrob. Agents Chemother. 46:1059-1066.
12. Dathe, M., T. Wieprecht, H. Nikolenko, L. Handel, W. L. Maloy, D. L. MacDonald, M. Beyermann, and M. Bienert. 1997. Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett. 403:208-212.
13. Efron, L., A. Dagan, L. Gaidukov, H. Ginsburg, and A. Mor. 2002. Direct interaction of dermaseptin S4 aminoheptanoyl derivative with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture. J. Biol. Chem. 277:24067-24072.
14. Feder, R., A. Dagan, and A. Mor. 2000. Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. J. Biol. Chem. 275:4230-4238.
15. Friedrich, C. L., D. Moyles, T. J. Beveridge, and R. E. Hancock. 2000. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. 44:2086-2092.
16. Gaidukov, L., A. Fish, and A. Mor. 2003. Analysis of membrane-binding properties of dermaseptin analogues: relationships between binding and cytotoxicity. Biochemistry 42:12866-12874.
17. Ganz, T. 2003. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3:710-720.
18. Ge, Y., D. L. MacDonald, K. J. Holroyd, C. Thornsberry, H. Wexler, and M. Zasloff. 1999. In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob. Agents Chemother. 43:782-788.
19. Hancock, R. E. 2001. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 1:156-164.
20. Hariton-Gazal, E., R. Feder, A. Mor, A. Graessmann, R. Brack-Werner, D. Jans, C. Gilon, and A. Loyter. 2002. Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals. Biochemistry 41:9208-9214.
21. Harwig, S. S., A. Waring, H. J. Yang, Y. Cho, L. Tan, and R. I. Lehrer. 1996. Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations. Eur. J. Biochem. 240:352-357.
22. Houston, M. E., Jr., L. H. Kondejewski, D. N. Karunaratne, M. Gough, S. Fidai, R. S. Hodges, and R. E. Hancock. 1998. Influence of preformed alpha-helix and alpha-helix induction on the activity of cationic antimicrobial peptides. J. Pept. Res. 52:81-88.
23. Huang, H. W. 2000. Action of antimicrobial peptides: two-state model. Biochemistry 39:8347-8352.
24. Krugliak, M., R. Feder, V. Y. Zolotarev, L. Gaidukov, A. Dagan, H. Ginsburg, and A. Mor. 2000. Antimalarial activities of dermaseptin S4 derivatives. Antimicrob. Agents Chemother. 44:2442-2451.
25. Kustanovich, I., D. E. Shalev, M. Mikhlin, L. Gaidukov, and A. Mor. 2002. Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives. J. Biol. Chem. 277:16941-16951.
26. Larrick, J. W., M. Hirata, Y. Shimomoura, M. Yoshida, H. Zheng, J. Zhong, and S. C. Wright. 1993. Antimicrobial activity of rabbit CAP18-derived peptides. Antimicrob. Agents Chemother. 37:2534-2539.
27. Lockwood, N. A., J. R. Haseman, M. V. Tirrell, and K. H. Mayo. 2004. Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains. Biochem. J. 378:93-103.
28. Mai, J. C., Z. Mi, S. H. Kim, B. Ng, and P. D. Robbins. 2001. A proapoptotic peptide for the treatment of solid tumors. Cancer Res. 61:7709-7712.
29. Maloy, W. L., and U. P. Kari. 1995. Structure-activity studies on magainins and other host defense peptides. Biopolymers 37:105-122.
30. Merrifield, R. B., P. Juvvadi, D. Andreu, J. Ubach, A. Boman, and H. G. Boman. 1995. Retro and retroenantio analogs of cecropin-melittin hybrids. Proc. Natl. Acad. Sci. USA 92:3449-3453.
31. Mor, A., and P. Nicolas. 1994. Isolation and structure of novel defensive peptides from frog skin. Eur. J. Biochem. 219:145-154.
32. Mosca, D. A., M. A. Hurst, W. So, B. S. C. Viajar, C. A. Fujii, and T. J. Falla. 2000. IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis. Antimicrob. Agents Chemother. 44:1803-1808.
33. Navon-Venezia, S., R. Feder, L. Gaidukov, Y. Carmeli, and A. Mor. 2002. Antibacterial properties of dermaseptin S4 derivatives with in vivo activity. Antimicrob. Agents Chemother. 46:689-694.
34. Papo, N., A. Braunstein, Z. Eshhar, and Y. Shai. 2004. Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino acid peptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion. Cancer Res. 64:5779-5786.
35. Park, C. B., K. S. Yi, K. Matsuzaki, M. S. Kim, and S. C. Kim. 2000. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl. Acad. Sci. USA 97:8245-8250.
36. Peck-Miller, K. A., J. Blake, W. L. Cosand, R. P. Darveau, and H. P. Fell. 1994. Structure-activity analysis of the antitumor and hemolytic properties of the amphiphilic alpha-helical peptide, C18G. Int. J. Pept. Protein Res. 44:143-151.
37. Peschel, A. 2002. How do bacteria resist human antimicrobial peptides? Trends Microbiol. 10:179-186.
38. Peschel, A., R. W. Jack, M. Otto, L. V. Collins, P. Staubitz, G. Nicholson, H. Kalbacher, W. F. Nieuwenhuizen, G. Jung, A. Tarkowski, K. P. van Kessel, and J. A. van Strijp. 2001. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J. Exp. Med. 193:1067-1076.
39. Peschel, A., M. Otto, R. W. Jack, H. Kalbacher, G. Jung, and F. Gotz. 1999. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274:8405-8410.
40. Pouny, Y., D. Rapaport, A. Mor, P. Nicolas, and Y. Shai. 1992. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry 31:12416-12423.
41. Radzishevsky, I. S., S. Rotem, F. Zaknoon, L. Gaidukov, A. Dagan, and A. Mor. 2005. Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides. Antimicrob. Agents Chemother. 49:2412-2420.
42. Shalev, D. E., A. Mor, and I. Kustanovich. 2002. Structural consequences of carboxyamidation of dermaseptin S3. Biochemistry 41:7312-7317.
43. 4S4(1-13). J. Biol. Chem. 281:9432-9438.
44. Shimizu, M., Y. Shigeri, Y. Tatsu, S. Yoshikawa, and N. Yumoto. 1998. Enhancement of antimicrobial activity of neuropeptide Y by N-terminal truncation. Antimicrob. Agents Chemother. 42:2745-2746.
45. Tossi, A., L. Sandri, and A. Giangaspero. 2000. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55:4-30.
46. Tossi, A., M. Scocchi, M. Zanetti, R. Gennaro, P. Storici, and D. Romeo. 1997. An approach combining rapid cDNA amplification and chemical synthesis for the identification of novel, cathelicidin-derived, antimicrobial peptides. Methods Mol. Biol. 78:133-150.
47. Wu, M., E. Maier, R. Benz, and R. E. Hancock. 1999. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 38:7235-7242.
48. Wu, Z., F. Cocchi, D. Gentles, B. Ericksen, J. Lubkowski, A. Devico, R. I. Lehrer, and W. Lu. 2005. Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro. FEBS Lett. 579:162-166.
49. Yan, H., S. Li, X. Sun, H. Mi, and B. He. 2003. Individual substitution analogs of Mel(12-26), melittin's C-terminal 15-residue peptide: their antimicrobial and hemolytic actions. FEBS Lett. 554:100-104.
50. Yaron, S., T. Rydlo, D. Shachar, and A. Mor. 2003. Activity of dermaseptin K-4-S4 against foodborne pathogens. Peptides 24:1815-1821.
51. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.
52. Zasloff, M., B. Martin, and H. C. Chen. 1988. Antimicrobial activity of synthetic magainin peptides and several analogues. Proc. Natl. Acad. Sci. USA 85:910-913.
53. Zhang, L., and R. E. Hancock. 2000. Peptide antibiotics, p. 209-232. In D. Hughes and D. I. Andersson (ed.), Antibiotic resistance and antibiotic development. Harwood Academic, Amsterdam, The Netherlands.